SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001564590-19-009358
Filing Date
2019-03-26
Accepted
2019-03-26 16:35:31
Documents
27
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K alec-10k_20181231.htm 10-K 3249725
2 EX-21.1 alec-ex211_257.htm EX-21.1 1087
3 EX-23.1 alec-ex231_258.htm EX-23.1 2268
4 EX-31.1 alec-ex311_8.htm EX-31.1 17347
5 EX-31.2 alec-ex312_9.htm EX-31.2 17335
6 EX-32.1 alec-ex321_6.htm EX-32.1 9468
7 EX-32.2 alec-ex322_7.htm EX-32.2 9527
8 GRAPHIC g3bomctsrkba000003.jpg GRAPHIC 33242
9 GRAPHIC g3bomctsrkba000008.jpg GRAPHIC 20949
10 GRAPHIC g3bomctsrkba000017.jpg GRAPHIC 13947
11 GRAPHIC g3bomctsrkba000012.jpg GRAPHIC 35176
12 GRAPHIC g3bomctsrkba000019.jpg GRAPHIC 7751
13 GRAPHIC g3bomctsrkba000014.jpg GRAPHIC 9178
14 GRAPHIC g3bomctsrkba000004.jpg GRAPHIC 10993
15 GRAPHIC g3bomctsrkba000020.jpg GRAPHIC 14668
16 GRAPHIC g3bomctsrkba000009.jpg GRAPHIC 21253
17 GRAPHIC g3bomctsrkba000001.jpg GRAPHIC 22401
18 GRAPHIC g3bomctsrkba000013.jpg GRAPHIC 15021
19 GRAPHIC g3bomctsrkba000006.jpg GRAPHIC 20247
20 GRAPHIC g3bomctsrkba000011.jpg GRAPHIC 8870
21 GRAPHIC g3bomctsrkba000015.jpg GRAPHIC 14011
22 GRAPHIC g3bomctsrkba000005.jpg GRAPHIC 29576
23 GRAPHIC g3bomctsrkba000018.jpg GRAPHIC 16199
24 GRAPHIC g3bomctsrkba000016.jpg GRAPHIC 15155
25 GRAPHIC g3bomctsrkba000002.jpg GRAPHIC 14633
26 GRAPHIC g3bomctsrkba000010.jpg GRAPHIC 15449
27 GRAPHIC g3bomctsrkba000007.jpg GRAPHIC 19605
  Complete submission text file 0001564590-19-009358.txt   3804420
Mailing Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080
Business Address 151 OYSTER POINT BLVD., SUITE 300 SOUTH SAN FRANCISCO CA 94080 415-231-5660
Alector, Inc. (Filer) CIK: 0001653087 (see all company filings)

IRS No.: 462702363 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38792 | Film No.: 19705677
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences